AG
Aristippos Gennadios
Group Pres. Pharma & Consumer

Aristippos Gennadios insider trades: Catalent (CTLT) stock sales

Group Pres. Pharma & Consumer, Catalent Last trade Aug 2, 2024 36 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2015
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Aristippos reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 2, 2024CTLT↓ Sell$70K
Jul 29, 2024CTLT↓ Sell$20K
Aug 24, 2023CTLT↓ Sell$18K
Aug 1, 2023CTLT↓ Sell$13K
Aug 25, 2022CTLT↓ Sell$170K
Jul 26, 2022CTLT↓ Sell$43K
Aug 27, 2021CTLT↓ Sell$297K
Jul 26, 2021CTLT↓ Sell$53K
Jan 4, 2021CTLT↓ Sell$11K
Dec 21, 2020CTLT↓ Sell$1.4M
Jun 25, 2020CTLT↓ Sell$608K
Nov 25, 2019CTLT↓ Sell$2.4M
Mar 21, 2019CTLT↓ Sell$143K
Apr 1, 2015CTLT↓ Sell$761K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Aristippos Gennadios's insider trades

Aristippos Gennadios is Group Pres. Pharma & Consumer at Catalent (CTLT). Since Apr 1, 2015, Aristippos has reported no open-market purchases and 14 sales worth $6.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (27 filings), shares withheld for taxes (10 filings), option exercises (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CTLT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.